[ad_1] Immunovant stock falls 8% amid Graves’ disease program update [ad_2] Source: Seekingalpha
Browsing: update
[ad_1] designer491/iStock by way of Getty Images Immunovant (NASDAQ:IMVT) stock fell 8% Monday after it reported knowledge from a Phase 2a research of batoclimab within the…
[ad_1] Applied DNA stock jumps amid U.S. government mpox update [ad_2] Source: Seekingalpha
[ad_1] Janux initiated at Stifel with Buy on upcoming data update [ad_2] Source: Seekingalpha
[ad_1] Applied DNA stock jumps amid U.S. government mpox update [ad_2] Source: Seekingalpha
[ad_1] Janux initiated at Stifel with Buy on upcoming data update [ad_2] Source: Seekingalpha
[ad_1] Applied DNA stock jumps amid U.S. government mpox update [ad_2] Source: Seekingalpha
[ad_1] Janux initiated at Stifel with Buy on upcoming data update [ad_2] Source: Seekingalpha
[ad_1] Avadel says court denies Jazz Pharma request on lumryz in narcolepsy (replace) [ad_2] Source: Seekingalpha
(*3*) Palatin stock climbs 8% on Phase 3 testing update for PL9643 [ad_2] Source: Seekingalpha